T Vischer
Overview
Explore the profile of T Vischer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
390
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kvien T, Gaston J, Bardin T, Butrimiene I, Dijkmans B, Leirisalo-Repo M, et al.
Ann Rheum Dis
. 2004 Aug;
63(9):1113-9.
PMID: 15308521
Objective: To determine the efficacy of weekly treatment with oral azithromycin for 13 weeks on the severity and resolution of reactive arthritis (ReA). Methods: 186 patients from 12 countries were...
2.
Buttgereit F, Da Silva J, Boers M, Burmester G, Cutolo M, Jacobs J, et al.
Ann Rheum Dis
. 2002 Jul;
61(8):718-22.
PMID: 12117678
In rheumatology and other medical specialties there is a discrepancy between the widespread use and the imprecise designation of glucocorticoid treatment regimens. Verbal descriptions of glucocorticoid treatment regimens used in...
3.
Furst D, Breedveld F, Burmester G, Crofford L, Emery P, Feldman M, et al.
Ann Rheum Dis
. 1999 Dec;
58 Suppl 1:I129-30.
PMID: 10577989
No abstract available.
4.
Finckh A, Morabia A, Deluze C, Vischer T
Arthritis Care Res
. 1998 Jul;
11(2):116-23.
PMID: 9668734
Objective: To compare the validity of self-reported questionnaires as response criteria of treatment efficacy in patients with fibromyalgia syndrome. Method: At the beginning of the treatment period, 70 fibromyalgia patients,...
5.
Bas S, Djavad N, Schwager J, Vischer T, Roosnek E
Autoimmunity
. 1998 Jun;
27(4):191-9.
PMID: 9623496
Among the rheumatoid factors (RFs), monospecific and polyspecific types can be distinguished. However the molecular basis responsible for their different specificity is not well understood. In a previous report, we...
6.
Desgeorges A, Gabay C, Silacci P, Novick D, Roux-Lombard P, Grau G, et al.
J Rheumatol
. 1997 Aug;
24(8):1510-6.
PMID: 9263143
Objective: To determine levels of soluble interleukin 6 receptor-alpha (sIL-6R alpha) in synovial fluid (SF) and serum from patients with different rheumatic diseases, and to analyze its cellular origin compared...
7.
Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer J, et al.
J Rheumatol
. 1997 Feb;
24(2):303-8.
PMID: 9034987
Objective: To investigate the difference in acute phase protein responses between patients with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and spondyloarthropathies (SpA). Methods: Circulating levels of cytokines inducing the...
8.
Djavad N, Bas S, Shi X, Schwager J, Jeannet M, Vischer T, et al.
Eur J Immunol
. 1996 Oct;
26(10):2480-6.
PMID: 8898963
We analyzed the rheumatoid factors (RF) produced by Epstein-Barr virus-transformed monoclonal B cells established from four patients with rheumatoid arthritis (RA), three individuals with a history of Mycobacterium tuberculosis (TB)...
9.
Gabay C, Singwe M, Genin B, Meyer O, Mentha G, LeCoultre C, et al.
Clin Exp Immunol
. 1996 Aug;
105(2):260-5.
PMID: 8706331
To investigate the contribution of IL-11 and LIF to acute-phase protein (APP) production, we first analysed the effects of IL-11 and LIF on production of C-reactive protein (CRP), fibrinogen, and...
10.
Weber M, Isler M, Dalvit G, von Kanel S, Aeschlimann A, Schwarz H, et al.
Praxis (Bern 1994)
. 1996 Mar;
85(11):337-9.
PMID: 8643893
The Swiss League against Rheumatic diseases in collaboration with rheumatologists organized a special educational program for general practitioners. An evaluation questionnaire was filled in by 238 of the 243 participants....